Organon & Co. (OGN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 21, 2025

$15.39

P/E Ratio

4.62

Market Cap

$3.97B

Description
Add to research
View more

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Metrics
Add to research
View more

Overview

  • HQJersey City, NJ
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerOGN
  • Price$15.39-1.35%

Trading Information

  • Market cap$3.97B
  • Float99.73%
  • Average Daily Volume (1m)4,199,496
  • Average Daily Volume (3m)3,259,162
  • EPS$3.36

Company

  • Revenue$6.40B
  • Rev growth (1yr)2.24%
  • Net income$864.00M
  • Gross margin58.02%
  • EBITDA margin27.72%
  • EBITDA$1.78B
  • EV$12.23B
  • EV/Revenue1.91
  • P/E4.62
  • P/S0.62
  • P/B8.41
  • Debt/Equity1,914.41
Documents
Add to research
View more